Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takamitsu Inoue

Showing results (131-140 of 185) with videos related to

Pageof 19
Sort By:
Scientific Reports|September 15, 2019
Increased fatty acyl saturation of phosphatidylinositol phosphates in prostate cancer progressionAtsushi Koizumi, Shintaro Narita, Hiroki Nakanishi, et al.
BMC Research Notes|October 21, 2016
Secondary bladder amyloidosis with familial Mediterranean fever in a living donor kidney transplant recipient: a case reportSentaro Imamura, Shintaro Narita, Ryuta Nishikomori, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 11, 2004
[Active chemotherapy with gemcitabine, carboplatin and docetaxel for three patients with MVAC-resistant liver metastasis of urothelial carcinoma]Takamitsu Inoue, Chikara Ohyama, Yohei Horikawa, et al.
International Journal of Cancer|August 30, 2008
Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese populationZhiyong Ma, Norihiko Tsuchiya, Takeshi Yuasa, et al.
World Journal of Surgical Oncology|January 5, 2012
Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancerShintaro Narita, Norihiko Tsuchiya, Teruaki Kumazawa, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 2015
[PRIMARY MEDIASTINAL GERM CELL TUMOR ARISING IN A PATIENT WITH NEUROFIBROMATOSIS TYPE 1]Soki Kashima, Mitsuru Saito, Norihiko Tsuchiya, et al.
International Urology and Nephrology|August 22, 2018
Can single positive core prostate cancer at biopsy be considered a low-risk disease?Hayato Yamamoto, Takuya Koie, Teppei Ookubo, et al.
Oncology Research|July 25, 2013
In vivo selection of high-metastatic subline of bladder cancer cell and its characterizationNaoki Sugiyama, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, et al.
Hinyokika Kiyo. Acta Urologica Japonica|July 26, 2016
[Outcome of Resection of Inferior Vena Cava Superior to the Renal Vein in Renal Cell Carcinoma with Vena Caval Tumor Thrombus]Soki Kashima, Shintaro Narita, Mitsuru Saito, et al.
In Vivo (Athens, Greece)|November 4, 2020
Does the Addition of Abiraterone to Castration Affect the Reduction in Bone Mineral Density?Shiori Nakajima, Takamitsu Inoue, Mingguo Huang, et al.
Pageof 19

Showing results (131-140 of 185) with videos related to

Sort By:
Pageof 19
Scientific Reports|September 15, 2019
Increased fatty acyl saturation of phosphatidylinositol phosphates in prostate cancer progressionAtsushi Koizumi, Shintaro Narita, Hiroki Nakanishi, et al.
BMC Research Notes|October 21, 2016
Secondary bladder amyloidosis with familial Mediterranean fever in a living donor kidney transplant recipient: a case reportSentaro Imamura, Shintaro Narita, Ryuta Nishikomori, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 11, 2004
[Active chemotherapy with gemcitabine, carboplatin and docetaxel for three patients with MVAC-resistant liver metastasis of urothelial carcinoma]Takamitsu Inoue, Chikara Ohyama, Yohei Horikawa, et al.
International Journal of Cancer|August 30, 2008
Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese populationZhiyong Ma, Norihiko Tsuchiya, Takeshi Yuasa, et al.
World Journal of Surgical Oncology|January 5, 2012
Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancerShintaro Narita, Norihiko Tsuchiya, Teruaki Kumazawa, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 2015
[PRIMARY MEDIASTINAL GERM CELL TUMOR ARISING IN A PATIENT WITH NEUROFIBROMATOSIS TYPE 1]Soki Kashima, Mitsuru Saito, Norihiko Tsuchiya, et al.
International Urology and Nephrology|August 22, 2018
Can single positive core prostate cancer at biopsy be considered a low-risk disease?Hayato Yamamoto, Takuya Koie, Teppei Ookubo, et al.
Oncology Research|July 25, 2013
In vivo selection of high-metastatic subline of bladder cancer cell and its characterizationNaoki Sugiyama, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, et al.
Hinyokika Kiyo. Acta Urologica Japonica|July 26, 2016
[Outcome of Resection of Inferior Vena Cava Superior to the Renal Vein in Renal Cell Carcinoma with Vena Caval Tumor Thrombus]Soki Kashima, Shintaro Narita, Mitsuru Saito, et al.
In Vivo (Athens, Greece)|November 4, 2020
Does the Addition of Abiraterone to Castration Affect the Reduction in Bone Mineral Density?Shiori Nakajima, Takamitsu Inoue, Mingguo Huang, et al.
Pageof 19